E131 844
The
Platinum
Hall of Fame
2012
Salvage Radical Prostatectomy for Radiation-recurrent
Prostate Cancer: A Multi-institutional Collaboration
D. Chade, S. Shariat, A. Cronin, C. Savage, J. Karnes, M. Blute,
A. Briganti, F. Montorsi, H. van der Poel, H. Van Poppel, S. Joniau,
G. Godoy, A. Hurtado-Coll, M. Gleave, M. Dall’Oglio, M. Srougi,
P. Scardino, J. Eastham
European Urology 2011;60:205–210
2013
Stage-Specific Impact of Tumor Location on Oncologic
Outcomes in Patients With Upper and Lower Tract
Urothelial Carcinoma Following Radical Surgery
M. Rink, B. Ehdaie, E.K. Cha, D.A. Green, P.I. Karakiewicz,
M. Babjuk, V. Margulis, J.D. Raman, R.S. Svatek, H. Fajkovic, R.K. Lee,
G. Novara, J. Hansen, S. Daneshmand, Y. Lotan, W. Kassouf,
H.-M. Fritsche, A. Pycham, M. Fisch, D.S. Scherr, S.F. Shariat, for the
Bladder Cancer Research Consortium (BCRC) and for the Upper Tract
Urothelial Carcinoma Collaboration (UTUCC)
European Urology 2012;62:677–684
2014
Natural History of Early, Localized Prostate Cancer:
A Final Report from Three Decades of Follow-up
M. Popiolek, J.R. Rider, O. Andrén, S.-O. Andersson, L. Holmberg,
H.-O. Adami, J.-E. Johansson
European Urology 2013;63:428–435
2015
Targeted Prostate Cancer Screening in BRCA1 and
BRCA2 Mutation Carriers: Results from the Initial
Screening Round of the IMPACT Study
E.K. Bancroft, E.C. Page, E. Castro, H. Lilja, A. Vickers, D. Sjoberg,
M. Assel, C.S. Foster, G. Mitche, K. Drew, L. Mæhle, K. Axcrona,
D.G. Evans, B. Bulman, D. Eles, D. McBride, C. van Asperen,
H. Vasen, L.A. Kiemeney, J. Ringelberg, C. Cybulski, D. Wokolorczyk,
C. Selkirk, P.J. Hulick, A. Bojesen, A.-B. Skytte, Jiy Lam, L. Taylor,
R. Oldenburg, R. Cremers, G. Verhaegh, W.A. van Zelst-Stams,
J.C. Oosterwijk, I. Blanco, M. Salinas, Jackie Ck, D.J. Rosario, S. Buys,
T. Conner, M.G. Ausems, K.-r. Ong, J. Homan, S. Domchek,
J. Powers, M.R. Teixeira, S. Maia, W.D. Foulkes, N. Taherian, M. Ruijs,
A.T. Helderman-van den Enden, L. Izatt, R. Davidson, M.A. Adank,
L. Walker, R. Schmutzler, K. Tucker, J. Kirk, S. Hodgson, M. Harris,
F. Douglas, G.J. Lindeman, J. Zgajnar, M. Tischkowitz, V.E. Clowes,
R. Susman, T. Ramón y Cajal, N. Patcher, N. Gadea, A. Spigelman,
T. van Os, A. Liljegren, L. Side, C. Brewer, A.F. Brady, A. Donaldson,
V. Stefansdottir, E. Friedman, R. Chen-Shtoyerman, D.J. Amor,
L. Copakova, J. Barwell, V.N. Giri, V. Murthy, N. Nicolai, S.-H. Teo,
L. Grnhalgh, S. Strom, A. Henderson, J. McGrath, D. Gallagher,
N. Aaronson, A. Ardern-Jones, C. Bangma, D. Dearnaley, P. Costello,
J. Eyfjord, J. Rothwell, A. Falconer, H. Gronberg, F.C. Hamdy,
O. Johannsson, V. Kh, Z. Kote-Jarai, J. Lubinski, U. Axcrona, J. Melia,
J. McKinley, A.V. Mitra, C. Moynihan, G. Rennert, M. Suri, P. Wilson,
E. Killick, The IMPACT Collaborators, S. Moss, R.A. Eeles
European Urology 2014;66:489–499
2016
Molecular Characterization of Enzalutamide-treated
Bone Metastatic Castration-resistant Prostate Cancer
E. Efstathiou, M. Titus, S. Wen, A. Hoang, M. Karlou , R. Ashe,
S.M. Tu, A. Aparicio, P. Troncoso, J. Mohler, C.J. Logothetis
European Urology 2015;6:53–60
2017
Tissue-based Genomics Augments Post-prostatectomy
Risk Stratification in a Natural History Cohort of
Intermediate- and High-Risk Men
A.E. Ross, M.H. Johnson, K. Yousefi, E. Davicioni, G.J. Netto,
L. Marchionni, H.L. Fedor, S. Glavaris, V. Choeurng, C. Buerki,
N. Erho, L.L. Lam, E.B. Humphreys, S. Faraj, S.M. Bezerra, M. Han,
A.W. Partin, B.J. Trock, E.M. Schaeffer
European Urology 2016;69:157–165
Best Scientific Paper on Clinical Research
2007
Depressed Contractile Responses to Neurokinin A
in Idiopathic but not Neurogenic Overactive Human
Detrusor Muscle
D.J. Sellers, C.R. Chapple, D.P.W. Hay, R. Chess-Williams
European Urology 2006;49:510–518
2008
Effects of the M3 Receptor Selective Muscarinic
Antagonist Darifenacin on Bladder Afferent Activity of
the Rat Pelvic Nerve
K. Iijima, S. De Wachter, J.-J. Wyndaele
European Urology 2007;52:842–849
2009
Marked Gene Transcript Level Alterations Occur Early
During Radical Prostatectomy
T. Schlomm, E. Näkel, A. Lübke, A. Buness, F.K.-H. Chun, T. Steuber,
M. Graefen, R. Simon, G. Sauter, A. Poustka, H. Huland,
A. Erbersdobler, H. Sültmann, O.J.C. Hellwinkel
European Urology 2008;53:333–346
2010
Characteristics of Spontaneous Activity in the Bladder
Trigone
A. Roosen, C. Wu, G. Sui, R.A. Chowdhury, P.M. Patel, C.H. Fry
European Urology 2009;56:346–354
Sponsored By Elsevier
2011
Stem Cell Characteristics in Prostate Cancer Cell Lines
M.J. Pfeiffer, J.A. Schalken
European Urology
2010;57:246–255
Sponsored By Elsevier
2012
Transplantation of Autologous Differentiated
Urothelium in an Experimental Model of Composite
Cystoplasty
A. Turner, R. Subramanian, D. Thomas, J. Hinley, S. Abbas,
J. Stahlschmidt, J. Southgate
European Urology 2011;59:447–454
2013
Genome-wide Analysis of CpG Island Methylation in
Bladder Cancer Identified TBX2, TBX3, GATA2, and ZIC4
as pTa-Specific Prognostic Markers
R. Kandimalla, A.A.G. van Tilborg, L.C. Kompier, D.J.P.M. Stumpel,
R.W. Stam, C.H. Bangma, E.C. Zwarthoff
European Urology 2012;61:1245–1256